Medicus Pharma Ltd. (MDCX)
About Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Net income
- -$47.3M
- Total assets
- $10.1M
- Market cap
- $21.0M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $21.0M
- Shares outstanding
- 8.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 22, 2023
Medicus Pharma Ltd. (MDCX) Stock Price
- Reported a net loss of $47.3M.
- Trading 98% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Medicus Pharma Ltd..
Write a review
News about Medicus Pharma Ltd.
News & sentiment via Polygon.io
Medicus Pharma Ltd.: frequently asked questions
Is Medicus Pharma Ltd. an American company?
Medicus Pharma Ltd. is a US-based company headquartered in W. Conshohocken, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Medicus Pharma Ltd. headquartered?
Medicus Pharma Ltd. is headquartered in W. Conshohocken, Pennsylvania, United States.
Is Medicus Pharma Ltd. publicly traded?
Yes — Medicus Pharma Ltd. is a publicly traded company. Its stock trades under the ticker symbol MDCX on the NASDAQ.
What does Medicus Pharma Ltd. do?
Medicus Pharma Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.
